Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Lloyd, Sansom"'
Autor:
Nicholas. R Latimer, Daniel Pollard, Adrian Towse, Chris Henshall, Lloyd Sansom, Robyn L Ward, Andrew Bruce, Carla Deakin
Publikováno v:
BMC Health Services Research, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background It is increasingly common for two or more treatments for cancer to be combined as a single regimen. Determining value and appropriate payment for such regimens can be challenging. This study discusses these challenges, and possibl
Externí odkaz:
https://doaj.org/article/b1b72ee499994c958b5fe3a3fbbaff26
Publikováno v:
PLoS ONE, Vol 16, Iss 12, p e0261022 (2021)
AimThe aim of this scoping review was to determine the extent of off-patent prescription medicine use beyond registered indications in various Australian clinical settings.MethodThe review followed the Joanna Briggs Institute approach and reported us
Externí odkaz:
https://doaj.org/article/b796ccaf44e644598ab1618e45aa94d6
Autor:
Andrew Bruce, Carla Deakin, Nicholas Latimer, Lloyd Sansom, Chris Henshall, Daniel Pollard, Robyn L. Ward, Adrian Towse
Publikováno v:
BMC Health Services Research
BMC Health Services Research, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Health Services Research, Vol 21, Iss 1, Pp 1-9 (2021)
Background It is increasingly common for two or more treatments for cancer to be combined as a single regimen. Determining value and appropriate payment for such regimens can be challenging. This study discusses these challenges, and possible solutio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87fd8f0cb4e991b4d7922ca8af024f40
https://eprints.whiterose.ac.uk/173534/8/s12913-021-06425-0.pdf
https://eprints.whiterose.ac.uk/173534/8/s12913-021-06425-0.pdf
Autor:
Sean Tunis, Alexandre Lemgruber, Brian O'Rourke, Chris Henshall, Lloyd Sansom, Carole Longson, Hans Georg Eichler
Publikováno v:
Therapeutic innovationregulatory science. 48(3)
Pharmaceutical companies have a good understanding of the needs and requirements of regulatory bodies, but the evidence expectations of health technology assessment (HTA) and coverage/payer bodies are less well understood and addressed. This paper se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a566ae8f2f4c5774cb5c55cfa4595916
https://pubmed.ncbi.nlm.nih.gov/30235538
https://pubmed.ncbi.nlm.nih.gov/30235538
Publikováno v:
International Journal of Technology Assessment in Health Care. 32:167-174
Objectives: Treatment switching occurs when patients in a randomized clinical trial switch from the treatment initially assigned to them to another treatment, typically from the control to experimental treatment. This study discusses the issues this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::539eb8335e7ee3a9b527bc68acd0c774
https://doi.org/10.1017/s026646231600009x
https://doi.org/10.1017/s026646231600009x
Autor:
John Weber, Albert L. Juhasz, Matthew Rees, Tim Kuchel, Euan Smith, Lloyd Sansom, Allan Rofe, Ravi Naidu
Publikováno v:
Journal of Environmental Science and Health, Part A. 48:604-611
In this study, lead (Pb) bioaccessibility was assessed in peri-urban contaminated soils using a variety of established in vitro assays. Bioaccessibility data was then used to predict Pb relative bioavailability (RBA) using published in vivo-in vitro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9930a6f91674f437355a9161da457010
https://doi.org/10.1080/10934529.2013.731354
https://doi.org/10.1080/10934529.2013.731354
Objectives: Some countries make considerable effort to involve patients and patient groups in their health technology assessment (HTA) processes; others are only just considering or are yet to consider patient involvement in HTA.Methods: This comment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b507e401d893d8e42f771e4ab2af349
https://hdl.handle.net/11541.2/128587
https://hdl.handle.net/11541.2/128587
Autor:
Lloyd Sansom
Publikováno v:
Journal of Pharmacy Practice and Research. 44:297-299
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12b022e5422b86fd1bb33379733766c4
https://doi.org/10.1002/jppr.1045
https://doi.org/10.1002/jppr.1045
Autor:
Lloyd Sansom
Publikováno v:
Pharmaceutical Medicine. 24:89-92
Internationally, there is a growing use of cost-effectiveness analysis as part of the decision-making process for the subsidy of pharmaceuticals. This will continue as the cost of pharmaceuticals and the demands for health services increase within co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93683cf2536eddfc8b32d29beaa24060
https://doi.org/10.1007/bf03256802
https://doi.org/10.1007/bf03256802
Autor:
Bernd Marschner, Albert L. Juhasz, Matthew Rees, Allan Rofe, John Weber, Euan Smith, Ravi Naidu, Tim Kuchel, Lloyd Sansom
Publikováno v:
Environmental Science & Technology. 43:4503-4509
In this study, lead (Pb) bioaccessibility in contaminated soils was assessed using an in vitro method (SBRC) encompassing gastric (SBRC-G) and intestinal (SBRC-I) phases. Initially, bioaccessibility studies were performed with a Pb reference material
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8952ed85ded6eae8574cc73a872aa008
https://doi.org/10.1021/es803238u
https://doi.org/10.1021/es803238u